{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:17:21Z","timestamp":1768565841998,"version":"3.49.0"},"posted":{"date-parts":[[2024,8,31]]},"group-title":"Infectious Diseases (except HIV\/AIDS)","reference-count":29,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T00:00:00Z","timestamp":1725062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,2,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>\n                    To assess the prevalence, anatomical distribution, and correlates of\n                    <jats:italic>Neisseria gonorrhoeae<\/jats:italic>\n                    (NG) and\n                    <jats:italic>Chlamydia trachomatis<\/jats:italic>\n                    (CT) infections within an HIV pre-exposure prophylaxis (PrEP) program in Hanoi, Vietnam.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Cross-sectional, observational study<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Between January-December 2022, HIV PrEP program clients who were male at birth, \u226516 years old, reported \u22651 male sex partner in the prior 12 months, were enrolled. A questionnaire collected sociodemographics, sexual behaviors, and clinical data. CT\/NG testing was performed on self-collected urine, rectal, and pharyngeal specimens. Multivariate logistic regression was used to identify factors associated with infections.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among 529 participants, the prevalence of CT or NG was 28.9% (153\/529). The prevalence of NG was 14.4% (76\/529) and highest for pharyngeal infections (11.7%; 62\/528), while for CT, the prevalence was 20.4% (108\/529) and highest for rectal infections (15.0%; 74\/493). Symptoms in the prior week were reported by 45.8% (70\/153) of those with CT or NG infections. Among asymptomatic participants, there was a low prevalence of urethral CT (3.1%; 14\/457) and NG (0.9%; 4\/457). Condomless anal sex (aOR= 1.98; 95% CI: 1.27, 3.09) and sexualized drug use in the prior 6 months (aOR= 1.71; 95% CI: 1.09, 2.69) were associated with CT\/NG infections.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The study found a high prevalence of CT\/NG infections, particularly pharyngeal and rectal infections, within an HIV PrEP program in Hanoi, Vietnam. The findings suggest testing for urethral infections among asymptomatic individuals is of limited value. Further research is needed for STI prevention strategies and updated guidelines for CT\/NG screening in HIV PrEP programs in low- and middle-income countries.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2024.08.30.24312811","type":"posted-content","created":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T14:00:15Z","timestamp":1725112815000},"source":"Crossref","is-referenced-by-count":0,"title":["Routine Testing for Chlamydia and Gonorrhea in an HIV Pre-Exposure Prophylaxis Program in Hanoi, Vietnam: Implications for Low- and Middle-Income Countries"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2776-6458","authenticated-orcid":false,"given":"Paul C.","family":"Adamson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7990-8091","authenticated-orcid":false,"given":"Hao T.M.","family":"Bui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7142-9806","authenticated-orcid":false,"given":"Loc Q.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phuong T.","family":"Truong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ngan T.","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giang M.","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey D.","family":"Klausner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2025021322500758000_2024.08.30.24312811v2.1","unstructured":"World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Geneva, Switzerland.: World Health Organization; 2021. https:\/\/www.who.int\/publications\/i\/item\/9789240027077 (accessed 20 Jul2024)."},{"key":"2025021322500758000_2024.08.30.24312811v2.2","unstructured":"Centers for Disease Control and Prevention. Sexually Transmitted Infections Surveillance 2022. Atlanta: US Department of Health and Human Services; 2024. https:\/\/www.cdc.gov\/std\/statistics\/2022\/default.htm (accessed 12 May2024)."},{"key":"2025021322500758000_2024.08.30.24312811v2.3","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001185"},{"key":"2025021322500758000_2024.08.30.24312811v2.4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy182"},{"key":"2025021322500758000_2024.08.30.24312811v2.5","doi-asserted-by":"crossref","first-page":"e1917134","DOI":"10.1001\/jamanetworkopen.2019.17134","article-title":"Global Epidemiologic Characteristics of Sexually Transmitted Infections Among Individuals Using Preexposure Prophylaxis for the Prevention of HIV Infection: A Systematic Review and Meta-analysis","volume":"2","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2025021322500758000_2024.08.30.24312811v2.6","doi-asserted-by":"publisher","DOI":"10.1002\/JIA2.25673"},{"issue":"Suppl 6","key":"2025021322500758000_2024.08.30.24312811v2.7","first-page":"e25343","article-title":"Diagnosing sexually transmitted infections in resource-constrained settings: challenges and ways forward","volume":"22","year":"2019","journal-title":"J Int AIDS Soc"},{"key":"2025021322500758000_2024.08.30.24312811v2.8","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000001626"},{"key":"2025021322500758000_2024.08.30.24312811v2.9","unstructured":"Vietnam Authority for HIV Prevention and Control. Guideline on implementation HIV preexposure prophylaxis (PrEP) services (Document No. 133). Vietnam Ministry of Health.; 2020."},{"key":"2025021322500758000_2024.08.30.24312811v2.10","doi-asserted-by":"crossref","first-page":"e26054","DOI":"10.1002\/jia2.26054","article-title":"Prevalence of sexualized drug use and risk of HIV among sexually active MSM in East and South Asian countries: systematic review and meta-analysis","volume":"26","year":"2023","journal-title":"Journal of the International AIDS Society"},{"key":"2025021322500758000_2024.08.30.24312811v2.11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/09564624211056749","article-title":"Sexually transmitted infections incidence in young Thai men who have sex with men and transgender women using HIV pre-exposure prophylaxis","volume":"33","year":"2022","journal-title":"Int J STD AIDS"},{"key":"2025021322500758000_2024.08.30.24312811v2.12","unstructured":"World Health Organization. WHO implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection. Module 13. Integrating STI services. Geneva, Switzerland.:; 2022. https:\/\/www.who.int\/publications\/i\/item\/9789240057425 (accessed 11 Jun2024)."},{"key":"2025021322500758000_2024.08.30.24312811v2.13","doi-asserted-by":"publisher","DOI":"10.1086\/430704"},{"key":"2025021322500758000_2024.08.30.24312811v2.14","doi-asserted-by":"crossref","unstructured":"Aboud L , Xu Y , Chow EPF , Wi T , Baggaley R , Mello MB , et al. Diagnostic accuracy of pooling urine, anorectal, and oropharyngeal specimens for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae: a systematic review and meta-analysis. BMC Med 2021; 19:285.","DOI":"10.1186\/s12916-021-02160-9"},{"key":"2025021322500758000_2024.08.30.24312811v2.15","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1097\/OLQ.0000000000001558","article-title":"Pooled 3-Anatomic-Site Testing for Chlamydia trachomatis and Neisseria gonorrhoeae: A Systematic Review and Meta-Analysis","volume":"48","year":"2021","journal-title":"Sexually Transmitted Diseases"},{"key":"2025021322500758000_2024.08.30.24312811v2.16","unstructured":"Centers for Disease Control and Prevention. Preexposure prophylaxis for the prevention of HIV infection in the United States\u20142021 Update: a clinical practice guideline.; 2021. https:\/\/www.cdc.gov\/hiv\/pdf\/risk\/prep\/cdc-hiv-prep-guidelines-2021.pdf (accessed 12 Jun2024)."},{"key":"2025021322500758000_2024.08.30.24312811v2.17","unstructured":"British HIV Association, British Association of Sexual Health and HIV. BHIVA\/BASHH guidelines on the use of HIV pre-exposure prophylaxis (PrEP), 2018.; 2018. https:\/\/www.bhiva.org\/PrEP-guidelines (accessed 12 Jun2024)."},{"key":"2025021322500758000_2024.08.30.24312811v2.18","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix439"},{"key":"2025021322500758000_2024.08.30.24312811v2.19","doi-asserted-by":"crossref","unstructured":"Reitsema M , van Hoek AJ , van der Loeff MS , Hoornenborg E , van Sighem A , Wallinga J , et al. Preexposure prophylaxis for men who have sex with men in the Netherlands: impact on HIV and Neisseria gonorrhoeae transmission and cost-effectiveness. AIDS 2020; 34:621.","DOI":"10.1097\/QAD.0000000000002469"},{"key":"2025021322500758000_2024.08.30.24312811v2.20","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0140-6736(18)31816-6","article-title":"Population effectiveness of opportunistic chlamydia testing in primary care in Australia: a cluster-randomised controlled trial","volume":"392","year":"2018","journal-title":"The Lancet"},{"key":"2025021322500758000_2024.08.30.24312811v2.21","doi-asserted-by":"crossref","unstructured":"Tsoumanis A , Hens N , Kenyon CR . Is Screening for Chlamydia and Gonorrhea in Men Who Have Sex With Men Associated With Reduction of the Prevalence of these Infections? A Systematic Review of Observational Studies. Sexually Transmitted Diseases 2018; 45:615.","DOI":"10.1097\/OLQ.0000000000000824"},{"key":"2025021322500758000_2024.08.30.24312811v2.22","doi-asserted-by":"crossref","unstructured":"Tao G , Patel CG , He L , Workowski K . STI\/HIV testing, STIs, and HIV PrEP use among men who have sex with men (MSM) and men who have sex with men and women (MSMW) in United States, 2019-2022. Clin Infect Dis 2024;: ciae314.","DOI":"10.1093\/cid\/ciae314"},{"key":"2025021322500758000_2024.08.30.24312811v2.23","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1016\/S2352-3018(23)00299-0","article-title":"Effect of screening for Neisseria gonorrhoeae and Chlamydia trachomatis on incidence of these infections in men who have sex with men and transgender women taking HIV pre-exposure prophylaxis (the Gonoscreen study): results from a randomised, multicentre, controlled trial","volume":"11","year":"2024","journal-title":". The Lancet HIV"},{"key":"2025021322500758000_2024.08.30.24312811v2.24","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00356-0"},{"key":"2025021322500758000_2024.08.30.24312811v2.25","doi-asserted-by":"crossref","unstructured":"Ridpath AD , Chesson H , Marcus JL , Kirkcaldy RD , Torrone EA , Aral SO , et al. Screening Peter to Save Paul: The Population-Level Effects of Screening Men Who Have Sex With Men for Gonorrhea and Chlamydia. Sexually Transmitted Diseases 2018; 45:623.","DOI":"10.1097\/OLQ.0000000000000892"},{"key":"2025021322500758000_2024.08.30.24312811v2.26","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-023453"},{"key":"2025021322500758000_2024.08.30.24312811v2.27","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ778"},{"key":"2025021322500758000_2024.08.30.24312811v2.28","doi-asserted-by":"crossref","first-page":"e447","DOI":"10.1016\/S2352-3018(19)30136-5","article-title":"Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study","volume":"6","year":"2019","journal-title":"The Lancet HIV"},{"key":"2025021322500758000_2024.08.30.24312811v2.29","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00230-5"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.08.30.24312811","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:10:42Z","timestamp":1768507842000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2024.08.30.24312811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,31]]},"references-count":29,"URL":"https:\/\/doi.org\/10.1101\/2024.08.30.24312811","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1097\/QAD.0000000000004203","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,8,31]]},"subtype":"preprint"}}